ClassID:

21254

A61K45/00 - CPC Classification

Classification description:

Medicinal preparations containing active ingredients not provided for in groups  - 

Sub-classes:
Recent Application in this class:
#1
20260144745
2026-05-28

Sugar Free Soft Chew Tablets

#2
20260132209
2026-05-14

COMPOSITION FOR TREATING IL-6-RELATED DISEASES

#3
20260130848
2026-05-14

METHODS AND COMPOSITIONS FOR CENTRAL NERVOUS SYSTEM (CNS) DRUG DELIVERY AND TREATMENT

#4
20260115235
2026-04-30

COMPOSITION FOR INDUCING PROLIFERATION OR ACCUMULATION OF REGULATORY T CELLS

#5
20260115197
2026-04-30

TREATMENT COMPOSITION FOR INHIBITING SYSTEMIC SCLEROSIS VIMENTIN MUTANT PROTEIN ACTIVITY BY USING STAT6 INHIBITOR

#6
20260098086
2026-04-09

COMPOSITION FOR PROPHYLAXIS OR TREATMENT OF IL-8 RELATED DISEASES

#7
20260097084
2026-04-09

PHARMACEUTICAL COMPOSITION CONTAINING CBFbeta-EXPRESSING VASCULAR SMOOTH MUSCLE CELLS OR CULTURE FLUID THEREOF AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF AGE-RELATED DISEASES

#8
20260085081
2026-03-26

PHOSPHATIDYLAMINE COMPOUNDS INCLUDING A PLURALITY OF TERTIARY AMINO GROUP STRUCTURES AND COMPOSITIONS THEREOF

#9
20260062755
2026-03-05

PREDICTION AND MONITORING OF IMMUNOTHERAPY IN CANCER

#10
20260061030
2026-03-05

COMPOSITIONS AND SYNERGISTIC METHODS FOR TREATING INFECTIONS

#11
20260027062
2026-01-29

IMPROVED ORAL PHARMACEUTICAL FORMULATIONS OF THERAPEUTIC PEPTIDES AND PROTEINS

#12
20260015672
2026-01-15

BIOMARKERS IN PANCREATIC CANCER

#13
20250375488
2025-12-11

COMPOSITION FOR INDUCING PROLIFERATION OR ACCUMULATION OF REGULATORY T CELLS

#14
20250352559
2025-11-20

Transdermal Delivery Composition for Delivery of at least one Glucose Controlling Agent, and Method of Delivering at least one Glucose Controlling Agent

#15
20250346642
2025-11-13

NEW SPLICE VARIANT ISOFORM OF VEGF

#16
20250340944
2025-11-06

METHOD TO ASSIST IN SCREENING FOR LATE RECURRENCE OF ER+ BREAST CANCER, AND METHOD FOR SCREENING THERAPEUTIC DRUGS

#17
20250312396
2025-10-09

Control of Cellular Redox Levels

#18
20250302916
2025-10-02

LIPOPROTEIN COMPLEXES AND MANUFACTURING AND USES THEREOF

#19
20250298019
2025-09-25

BORRELIA BURGDORFERI PEPTIDOGLYCAN DETECTION METHODS

#20
20250297315
2025-09-25

METHODS AND COMPOSITIONS FOR PROGNOSIS AND TREATMENT OF DILATED CARDIOMYOPATHY AND HEART FAILURE

#21
20250263385
2025-08-21

"Good" buffer-based cationic lipids

#22
20250243288
2025-07-31

COMPOSITION FOR TREATING IL-6-RELATED DISEASES

#23
20250235349
2025-07-24

LACRIMAL DRUG DELIVERY DEVICE

#24
20250214953
2025-07-03

SULFIDE-CONTAINING IONIZABLE LIPID AND LIPID NANOPARTICLE INCLUDING THE SAME

#25
20250213689
2025-07-03

IMMUNOGENIC COMPOSITION FOR THE TREATMENT OF CANCER

#26
20250197942
2025-06-19

METHODS OF SELECTING AND TREATING CANCER SUBJECTS THAT ARE CANDIDATES FOR TREATMENT USING INHIBITORS OF A PD-1 PATHWAY

#27
20250189528
2025-06-12

BIOMARKERS FOR DISEASE PROGRESSION AND/OR RECURRENCE IN SQUAMOUS CELL CARCINOMA

#28
20250177291
2025-06-05

HYPOTONIC GEL-FORMING FORMULATIONS WITH ENHANCED RHEOLOGICAL PROPERTIES

#29
20250108094
2025-04-03

METHODS AND COMPOSITIONS RELATED TO COMBINED TREATMENT WITH ANTI-INFLAMMATORIES AND SYNTHETIC NANOCARRIERS COMPRISING AN IMMUNOSUPPRESSANT

#30
20250099369
2025-03-27

TOPICAL DELIVERY COMPOSITIONS COMPRISING NON-STEROIDAL ANTI-INFLAMMATORY DRUGS

#31
20250090478
2025-03-20

Base Composition for Tape Agent

#32
20250082772
2025-03-13

ANTIBODY-DRUG CONJUGATE

#33
20250075182
2025-03-06

CELLULAR TARGETED ACTIVE INGREDIENT DELIVERY SYSTEM

#34
20250066853
2025-02-27

PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND/OR PREVENTION OF ANEURYSMS, DIAGNOSTIC SUPPORT METHOD FOR ANEURYSMS, AND METHOD FOR EVALUATING ANEURYSM THERAPEUTICS

#35
20250064936
2025-02-27

COMPOSITIONS AND METHODS FOR INHIBITION OF HAO1 (HYDROXYACID OXIDASE 1 (GLYCOLATE OXIDASE)) GENE EXPRESSION

#36
20250064633
2025-02-27

LACRIMAL DRUG DELIVERY DEVICE

#37
20250034650
2025-01-30

TRANSCRIPTIONAL BIOMARKERS FOR RESPONSE TO INNATE IMMUNE ACTIVATORS

#38
20250017846
2025-01-16

TOPICAL ANALGESICS

#39
20250000809
2025-01-02

Encapsulated biomolecules for intracellular delivery

#40
20250000789
2025-01-02

SYSTEM FOR RELEASING A HAEMOSTATIC AGENT INTO THE UTERINE CAVITY

#41
20240417480
2024-12-19

COMPOSITION FOR TREATING IL-6-RELATED DISEASES

#42
20240409650
2024-12-12

METHODS AND COMPOSITIONS FOR INCREASING N-ACETYLGLUCOSAMINIDASE ACTIVITY IN THE CNS

#43
20240400681
2024-12-05

METHOD FOR PRODUCING AN ANTI-LAG-3 ANTIBODY

#44
20240390411
2024-11-28

COMPOSITION COMPRISING GLYCOSAMINOGLYCAN DERIVATIVE AND CHEMOKINE RECEPTOR ACTIVITY REGULATOR

#45
20240390285
2024-11-28

HIGH-DOSE COMPRESSIBLE DOSAGE FORMS MANUFACTURED BY SIMULTANEOUS MELT-COATING AND MELT-GRANULATION OF ACTIVE PHARMACEUTICAL INGREDIENTS

#46
20240366624
2024-11-07

METHODS AND COMPOSITIONS FOR TREATING THROMBOTIC DISEASE

#47
20240360510
2024-10-31

DETECTION OF KDM1A LOSS OF ACTIVITY FOR DIAGNOSING ENDOCRINE DISORDERS

#48
20240344138
2024-10-17

TARGETED THERAPIES IN CANCER

#49
20240342084
2024-10-17

TRANSDERMAL SOLVENT SYSTEM AND METHODS OF USE

#50
20240335384
2024-10-10

NITROGEN-CONTAINING CATIONIC LIPID AND APPLICATION THEREOF

#51
20240307463
2024-09-19

COMPOSITION FOR INDUCING PROLIFERATION OR ACCUMULATION OF REGULATORY T CELLS

#52
20240307462
2024-09-19

Composition for inducing proliferation or accumulation of regulatory T cells

#53
20240307337
2024-09-19

Method Of Treatment Of Obesity

#54
20240299405
2024-09-12

APPLICATION OF ATP POTASSIUM CHANNEL MODIFIER IN PREPARATION OF ANTI-DIABETIC NEPHROPATHY DRUG

#55
20240294988
2024-09-05

METHODS OF DETERMINING RESPONSIVENESS TO CHEMOTHERAPEUTIC COMPOUNDS FOR CANCER THERAPY

#56
20240294910
2024-09-05

NOVEL THERAPEUTIC AGENT FOR SEPTICEMIA, AND A METHOD FOR SCREENING FOR SAME

#57
20240226300
2024-07-11

TREATMENT OF EXPOSURE TO VESICANTS

#58
20240216375
2024-07-04

USE OF SYMPATHETIC ACTIVATION INHIBITOR AND/OR ALPHA 1-ADRENERGIC RECEPTOR INHIBITOR IN PREPARING MEDICINE FOR TREATING DRY EYES

#59
20240165192
2024-05-23

STABLE ANTIBODY-DRUG CONJUGATE, PREPARATION METHOD THEREFOR, AND USE THEREOF

#60
20240165111
2024-05-23

ORGANIC COMPOUNDS

#61
20240156894
2024-05-16

STABLE ANTIBODY-DRUG CONJUGATE, PREPARATION METHOD THEREFOR, AND USE THEREOF

#62
20240150839
2024-05-09

METHODS FOR PREDICTING RESPONSIVENESS OF PROSTATE CANCER PATIENTS TO PARP INHIBITORS

#63
20240150477
2024-05-09

COMPOSITION FOR TREATING IL-6-RELATED DISEASES

#64
20240110926
2024-04-04

TNF-ALPHA AND IL-1ALPHA POSITIVE COPD TREATMENT WITH ANTIBIOTICS

#65
20240108608
2024-04-04

METHODS AND COMPOSITIONS FOR THE TREATMENT OF CORNEAL ENDOTHELIUM DISORDERS

#66
20240091335
2024-03-21

NOVEL THI-INDUCING ADJUVANT COMPRISING COMBINATION OF DIFFERENT NUCLEIC ACID ADJUVANTS AND USE OF SAME

#67
20240083996
2024-03-14

COMPOSITION FOR PROPHYLAXIS OR TREATMENT OF IL-8 RELATED DISEASES

#68
20240074968
2024-03-07

ORAL PHARMACEUTICAL COMPOSITION AND METHOD FOR PRODUCING PARTICULATE FORMULATION COMPRISING COMPOSITION

#69
20240060045
2024-02-22

CELLULAR TARGETED ACTIVE INGREDIENT DELIVERY SYSTEM

#70
20240036050
2024-02-01

Methods Of Detecting And Treating Hepatocellular Carcinoma

#71
20240019430
2024-01-18

AUTOANTIBODIES RELATED TO IGA NEPHROPATHY

#72
20240018249
2024-01-18

PHARMACEUTICAL COMPOSITION FOR PREVENTION AND/OR TREATMENT OF ATOPIC DERMATITIS COMPRISING IL-31 ANTAGONIST AS ACTIVE INGREDIENT

#73
20240016960
2024-01-18

CONJUGATES ENHANCING TOTAL CELLULAR ACCUMULATION

#74
20240000887
2024-01-04

Lipoprotein complexes and manufacturing and uses thereof

#75
20230405124
2023-12-21

GAMMA SECRETASE MODULATORS FOR THE TREATMENT OF IMMUNE SYSTEM DYSFUNCTION

#76
20230404933
2023-12-21

NON-CATIONIC SOFT POLYPHENOL NANOCAPSULES FOR EFFECTIVE SYSTEMIC DELIVERY OF SMALL INTERFERING RNA (siRNA) FOR CANCER TREATMENT

#77
20230372441
2023-11-23

Lipoprotein complexes and manufacturing and uses thereof

#78
20230364119
2023-11-16

AUTOPHAGY ACTIVATOR

#79
20230349924
2023-11-02

DETERMINATION AGENT AND DETERMINATION METHOD FOR TAUOPATHY AND DEMENTIA-RELATED DISEASES

#80
20230346845
2023-11-02

USES OF MSC IN IMPROVING THROMBOTIC COMPLICATIONS IN COVID-19 PNEUMONIA

#81
20230323475
2023-10-12

TEST METHOD, OF DIVIDING BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM (BPDCN) INTO SUBTYPES

#82
20230279101
2023-09-07

VEGF/DLL4 BINDING AGENTS AND USES THEREOF

#83
20230277665
2023-09-07

Safe and Effective Method of Treating Lupus with Anti-IL12/IL23 Antibody

#84
20230277546
2023-09-07

AGENT FOR SUPPRESSING POST-SURGICAL CANCER RECURRENCE AND/OR METASTASIS

#85
20230256054
2023-08-17

IMMUNITY ENHANCING AGENT FOR CANCER BY ALLERGIN-1 ANTAGONIST

#86
20230218638
2023-07-13

NEUROACTIVE COMPOUNDS AND METHODS OF USE THEREOF

#87
20230201263
2023-06-29

PRETREATMENT DRUG FOR T CELL INFUSION THERAPY FOR IMMUNE-CHECKPOINT INHIBITOR-RESISTANT TUMOR

#88
20230190899
2023-06-22

IMMUNE INDUCER

#89
20230190864
2023-06-22

PURIFIED AMPHIPHILIC PEPTIDE COMPOSITIONS AND USES THEREOF

#90
20230181576
2023-06-15

Organic compounds

#91
20230123729
2023-04-20

COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASES

#92
20230122491
2023-04-20

Base Composition for Tape Agent

#93
20230121944
2023-04-20

COMPOSITIONS AND METHODS FOR INHIBITION OF HAO1 (HYDROXYACID OXIDASE 1 (GLYCOLATE OXIDASE)) GENE EXPRESSION

#94
20230119275
2023-04-20

DRUG EFFECTIVE FOR LYMPHOGENOUS DRUG ADMINISTRATING METHOD

#95
20230119226
2023-04-20

Methods and compositions related to combined treatment with anti-inflammatories and synthetic nanocarriers comprising an immunosuppressant

#96
20230107561
2023-04-06

METHODS AND COMPOSITIONS RELATED TO COMBINED TREATMENT WITH ANTI-INFLAMMATORIES AND SYNTHETIC NANOCARRIERS COMPRISING AN IMMUNOSUPPRESSANT

#97
20230059640
2023-02-23

PROPHYLACTIC AND THERAPEUTIC PHARMACEUTICAL AGENT FOR HIV INFECTIOUS DISEASES CHARACTERIZED BY COMPRISING COMBINATION OF INTEGRASE INHIBITOR AND ANTI-HIV AGENT

#98
20230058726
2023-02-23

CHEMOPREVENTION USING CONTROLLED- RELEASE FORMULATIONS OF ANTI-INTERLEUKIN 6 AGENTS, SYNTHETIC VITAMIN A ANALOGUES OR METABOLITES, AND ESTRADIOL METABOLITES

#99
20230030982
2023-02-02

METHOD FOR TREATING CANCER BY ADMINISTRATION OF ANTIBODIES THAT BIND TO EXTRACELLULAR REGION PORTION OF MCEMP1 PROTEIN

#100
20230000989
2023-01-05

Low molecular weight cationic lipids for oligonucleotide delivery

#101
20220409566
2022-12-29

CCL5 inhibitors

#102
20220388981
2022-12-08

CRYSTALLINE FORMS OF A BIPHENYL COMPOUND

#103
20220362336
2022-11-17

LIPOPROTEIN COMPLEXES AND MANUFACTURING AND USES THEREOF

#104
20220354928
2022-11-10

METHODS AND COMPOSITIONS OF NEUREGULINS FOR PREVENTING, TREATING OR DELAYING PRESERVED EJECTION FRACTION CARDIAC FAILURE

#105
20220340970
2022-10-27

GENETIC POLYMORPHISMS ASSOCIATED WITH VENOUS THROMBOSIS AND STATIN RESPONSE, METHODS OF DETECTION AND USES THEREOF

#106
20220339243
2022-10-27

COMPOSITIONS AND SYNERGISTIC METHODS FOR TREATING INFECTIONS

#107
20220315927
2022-10-06

MODULATORS OF YAP1 EXPRESSION

#108
20220313818
2022-10-06

USE OF IL-17 ANTAGONISTS TO INHIBIT THE PROGRESSION OF STRUCTURAL DAMAGE IN PSORIATIC ARTHRITIC PATIENTS

#109
20220288166
2022-09-15

MICROVASCULAR BLOOD FLOW DECREASING AGENT AND USE THEREOF

#110
20220241196
2022-08-04

Transdermal solvent system and methods of use

#111
20220229077
2022-07-21

DIAGNOSIS, PROGNOSIS AND TREATMENT FOR SCHIZOPHRENIA AND SCHIZOAFFECTIVE PSYCHOSIS

#112
20220218670
2022-07-14

METHODS OF TREATING DISEASES CHARACTERISED BY VASOCONSTRICTION

#113
20220193014
2022-06-23

LIPID PHARMACEUTICAL PREPARATION AND APPLICATION THEREOF

#114
20220168237
2022-06-02

Flavonoid polyphenol drug self-emulsifying composition, preparation method therefor, pharmaceutical composition thereof and application thereof

#115
20220160729
2022-05-26

Replacement of Cytotoxic Preconditioning Before Cellular Immunotherapy

#116
20220152205
2022-05-19

MODULATING PERMEABILITY OF THE BLOOD CEREBROSPINAL FLUID BARRIER

#117
20220142961
2022-05-12

CCL5 inhibitors

#118
20220135631
2022-05-05

SECRETORY PROTEIN

#119
20220133776
2022-05-05

COMPOSITION INCLUDING GLUCOSAMINOGLYCAN DERIVATIVE AND CHEMOKINE RECEPTOR ACTIVITY REGULATOR

#120
20220133766
2022-05-05

MODULATION OF CILIOGENESIS

#121
20220096568
2022-03-31

COMPOSITION FOR INDUCING PROLIFERATION OR ACCUMULATION OF REGULATORY T CELLS

#122
20220088131
2022-03-24

COMPOSITIONS AND METHODS RELATING TO C5L2

#123
20220064288
2022-03-03

Anti-Human Transferrin Receptor Antibody Permeating Blood-Brain Barrier

#124
20220062037
2022-03-03

Lacrimal drug delivery device

#125
20220054506
2022-02-24

Immunoregulatory agent

#126
20220048881
2022-02-17

TRICYCLIC SPIRO COMPOUND

#127
20220047644
2022-02-17

FIBROBLASTS FOR TREATMENT OF DEGENERATIVE DISC DISEASE

#128
20220031803
2022-02-03

ANTIBACTERIAL COMPOSITION COMPRISING MICROCIN S AND ANTIBIOTIC

#129
20210401987
2021-12-30

METHODS AND COMPOSITIONS FOR TREATING INFLAMMATORY AND FIBROTIC PULMONARY DISORDERS

#130
20210401924
2021-12-30

Stable antibody-drug conjugate, preparation method therefor, and use thereof

#131
20210386865
2021-12-16

METHOD FOR SELECTIVELY MANUFACTURING ANTIBODY-DRUG CONJUGATE

#132
20210380671
2021-12-09

COMPOSITIONS TARGETING THE SOLUBLE EXTRACELLULAR DOMAIN OF E-CADHERIN AND RELATED METHODS FOR CANCER THERAPY

#133
20210361652
2021-11-25

Methods and formulations for modulating Lyn kinase activity and treating related disorders

#134
20210346311
2021-11-11

Base Composition for Tape Agent

#135
20210337777
2021-11-04

ATOPIC DERMATITIS MODEL NON-HUMAN ANIMAL AND USE THEREOF

#136
20210301011
2021-09-30

Composition for prophylaxis or treatment of IL-8 related diseases

#137
20210299239
2021-09-30

NOVEL TH1-INDUCING ADJUVANT COMPRISING COMBINATION OF DIFFERENT NUCLEIC ACID ADJUVANTS, AND USE OF SAME

#138
20210283060
2021-09-16

Fine nano-sized medicinal agent and use thereof

#139
20210270839
2021-09-02

SYSTEMS AND METHODS FOR ANALYZING PERSISTENT HOMEOSTATIC PERTURBATIONS

#140
20210268117
2021-09-02

Methods of preparing a pegylated human IL-11 composition

#141
20210259966
2021-08-26

Transdermal solvent system and methods of use

#142
20210251932
2021-08-19

Method of treatment of obesity

#143
20210236461
2021-08-05

Agent for eliminating senescent cells

#144
20210205234
2021-07-08

Sustained drug release sheet for treating nerve injury

#145
20210196665
2021-07-01

CCL5 inhibitors

#146
20210177929
2021-06-17

Stable antibody-drug conjugate, preparation method therefor, and use thereof

#147
20210177032
2021-06-17

METHODS AND FORMULATIONS PROMOTING TISSUE/ORGAN REGENERATION, LONGEVITY AND HEALTHSPAN

#148
20210154177
2021-05-27

PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF AUTISM

#149
20210154152
2021-05-27

GEL PATCH

#150
20210145803
2021-05-20

Pharmaceutical composition for the treatment of autism

#151
20210139608
2021-05-13

Bio-responsive adhesive antibody delivery platform for immunotherapy and preparation method thereof

#152
20210137790
2021-05-13

Method for the formulation of oil-soluble substances, and powders obtainable thereof

#153
20210123059
2021-04-29

Modulators of YAP1 expression

#154
20210061903
2021-03-04

VEGF/DLL4 binding agents and uses thereof

#155
20210060010
2021-03-04

ORGANIC COMPOUNDS

#156
20210038725
2021-02-11

STATIN-CONTAINING NANOPARTICLE PREPARATION FOR ENHANCING FUNCTION OF STEM CELLS FOR TREATING INFLAMMATORY DISEASE, AND FUNCTIONALLY ENHANCED STEM CELLS CONTAINING SAME FOR TREATING INFLAMMATORY DISEASE

#157
20210038502
2021-02-11

S1PR2 ANTAGONISTS FOR TREATING DISEASES INVOLVING ABNORMAL IMMUNE RESPONSES

#158
20210017286
2021-01-21

COMPOSITION FOR TREATING IL-6-RELATED DISEASES

#159
20210015747
2021-01-21

Composition for treating onychomycosis

#160
20210011030
2021-01-14

BLOCKADE OF TIM-1 PATHWAYS and P-SELECTIN PATHWAYS IN TREATMENT OF NEUROINFLAMMATORY DEGENERATIVE DISEASE

#161
20210011004
2021-01-14

METHOD FOR CHANGING CONDITION OF EYELID OF HAIRLESS ANIMAL

#162
20210009644
2021-01-14

Secretory protein

#163
20210000916
2021-01-07

Composition comprising poly I:C and LAG-3-IGG fusion protein

#164
20200405632
2020-12-31

TRANSCERVICAL TREATMENT OF GYNECOLOGICAL MALIGNANCIES

#165
20200384091
2020-12-10

METHOD OF TREATING DEPRESSION

#166
20200368317
2020-11-26

METHODS AND COMPOSITIONS OF NEUREGULINS FOR PREVENTING, TREATING OR DELAYING PRESERVED EJECTION FRACTION CARDIAC FAILURE

#167
20200353032
2020-11-12

LYTIC-PEPTIDE-HER2/NEU (HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2) LIGAND CONJUGATES AND METHODS OF USE

#168
20200353012
2020-11-12

CADAVERIC DERIVED WOUND TREATMENT AND METHOD OF USE

#169
20200339995
2020-10-29

Medicine for treating cancer and method for treating cancer

#170
20200338189
2020-10-29

Immunogenic sequences from a phage tail length tape measure protein, bacteria expressing the same and their use in treating a cancer

#171
20200323943
2020-10-15

MALIGNANT TUMOR TARGET PEPTIDE

#172
20200323933
2020-10-15

Echovirus for treatment of tumors

#173
20200317641
2020-10-08

Crystalline forms of a biphenyl compound

#174
20200316201
2020-10-08

Compositions and methods for inhibition of HAO1 (hydroxyacid oxidase 1 (glycolate oxidase)) gene expression

#175
20200315962
2020-10-08

ORAL PHARMACEUTICAL COMPOSITION AND METHOD FOR PRODUCING PARTICULATE FORMULATION COMPRISING COMPOSITION

#176
20200297723
2020-09-24

PHARMACOTHERAPY FOR PREVENTING OR TREATING GLAUCOMA

#177
20200289541
2020-09-17

Composition for ameliorating loss of hair and graying of hair, and use thereof

#178
20200276287
2020-09-03

Immunogenic composition for the treatment of cancer

#179
20200276141
2020-09-03

Compositions and methods for the treatment of cancer

#180
20200254096
2020-08-13

System for adding sensory conditioning cues in a pharmacotherapeutic regimen

#181
20200246459
2020-08-06

Compositions and methods for treating CNS disorders

#182
20200246399
2020-08-06

Composition for inducing proliferation or accumulation of regulatory T cells

#183
20200239419
2020-07-30

Intermediate compound of novel tetrahydronaphthyl urea derivative

#184
20200237915
2020-07-30

Cytomegalovirus vectors eliciting T cells restricted by major histocompatibility complex E molecules

#185
20200237687
2020-07-30

Isotope enhanced ambroxol for long lasting autophagy induction

#186
20200230088
2020-07-23

Coloured keratolytic nail lacquer

#187
20200230054
2020-07-23

SELECTIVE RELEASE SYSTEM FOR TUMOR THERAPEUTIC AGENTS AND TUMOR DIAGNOSTIC AGENTS AND BIOSENSOR FOR TUMOR TISSUE

#188
20200222540
2020-07-16

Low molecular weight cationic lipids for oligonucleotide delivery

#189
20200216912
2020-07-09

METHOD FOR SUPPRESSING BRAIN METASTASIS

#190
20200216904
2020-07-09

Diagnostic methods for infectious disease using endogenous gene expression

#191
20200197517
2020-06-25

Safe and Effective Method of Treating Lupus with Anti-IL12/IL23 Antibody

#192
20200190184
2020-06-18

Screening method for pain suppressor and pharmaceutical composition for prevention or treatment of pain

#193
20200190141
2020-06-18

Peptide for inhibiting skin inflammation and composition for preventing or treating skin inflammation containing the same

#194
20200172528
2020-06-04

Small molecule inhibitors of MYC and uses thereof

#195
20200138951
2020-05-07

FKBP52-TAU INTERACTION AS A NOVEL THERAPEUTICAL TARGET FOR TREATING THE NEUROLOGICAL DISORDERS INVOLVING TAU DYSFUNCTION

#196
20200138829
2020-05-07

METHODS OF CANCER TREATMENT

#197
20200138766
2020-05-07

CCL5 inhibitors

#198
20200129458
2020-04-30

COMPOUND HAVING ENHANCING ACTIVITY FOR GLUCAGON-LIKE PEPTIDE-1 RECEPTOR ACTIONS

#199
20200123253
2020-04-23

Antibody for treating autoimmune diseases

#200
20200102396
2020-04-02

Pharmaceutical composition for prevention and/or treatment of atopic dermatitis comprising IL-31 antagonist as active ingredient

#201
20200102294
2020-04-02

Compositions and methods for treating neurodegenerative diseases

#202
20200102284
2020-04-02

Tricyclic spiro compound

#203
20200085897
2020-03-19

Extract of aerial parts of Maca rich in polyphenols and composition comprising same

#204
20200071308
2020-03-05

Benzene, Pyridine, and Pyridazine Derivatives

#205
20200061039
2020-02-27

Pyridinone compound and use thereof

#206
20200061031
2020-02-27

METHOD FOR TREATING EGFR-TKI-RESISTANT NON-SMALL CELL LUNG CANCER BY ADMINISTRATION OF ANTI-HER3 ANTIBODY-DRUG CONJUGATE

#207
20200041521
2020-02-06

CANCER DIAGNOSIS AND THERAPY

#208
20200038400
2020-02-06

Drug effective for lymphogenous drug administrating method

#209
20200038397
2020-02-06

PHARMACOTHERAPY FOR PREVENTING OR TREATING GLAUCOMA

#210
20200033339
2020-01-30

Compositions, methods and kits to detect herpes simplex virus nucleic acids

#211
20200030249
2020-01-30

Peelable nail lacquer

#212
20200000738
2020-01-02

Base Composition for Tape Agent

#213
20190365909
2019-12-05

Methods of treatment using a branched amino terminal pegylated Il-11 composition

#214
20190365908
2019-12-05

Interleukin-11 PEGylation reaction intermediate composition

#215
20190352380
2019-11-21

COMPOSITIONS TARGETING THE SOLUBLE EXTRACELLULAR DOMAIN OF E-CADHERIN AND RELATED METHODS FOR CANCER THERAPY

#216
20190337897
2019-11-07

Tetrahydronaphthyl urea derivative

#217
20190321362
2019-10-24

Methods and formulations for modulating Lyn kinase activity and treating related disorders

#218
20190315756
2019-10-17

BRK inhibitory compound

#219
20190309102
2019-10-10

Antibody-drug conjugate having cyclic benzylidene acetal linker

#220
20190300958
2019-10-03

GENETIC POLYMORPHISMS ASSOCIATED WITH VENOUS THROMBOSIS AND STATIN RESPONSE, METHODS OF DETECTION AND USES THEREOF

#221
20190298800
2019-10-03

Lipoprotein complexes and manufacturing and uses thereof

#222
20190293647
2019-09-26

Circulating astrocytes and MFSD2A as biomarkers

#223
20190282699
2019-09-19

THIOLATED HYALURONAN-BASED HYDROGELS CROSS-LINKED USING OXIDIZED GLUTATHIONE

#224
20190282635
2019-09-19

Composition for inducing proliferation or accumulation of regulatory T cells

#225
20190282634
2019-09-19

Composition for inducing proliferation or accumulation of regulatory T cells

#226
20190275091
2019-09-12

Anticancer agent comprising HVJ-E and immune checkpoint protein inhibitor

#227
20190274877
2019-09-12

Lacrimal drug delivery device

#228
20190269806
2019-09-05

Isotope enhanced ambroxol for long lasting autophagy induction

#229
20190255182
2019-08-22

CTB-PI polyamide conjugate for activating expression of specific gene

#230
20190247425
2019-08-15

RUNX inhibitor

#231
20190247384
2019-08-15

Composition for activating neurogenesis

#232
20190240243
2019-08-08

Agent for treating retinopathy

#233
20190225704
2019-07-25

Antibody binding to TMEM132A, anticancer agent, and cancer test method

#234
20190216839
2019-07-18

Pharmaceutical composition for treating and/or preventing cancer

#235
20190202911
2019-07-04

Methods for treating autoimmune diseases incorporating an anti-LAG3 antibody

#236
20190201488
2019-07-04

COMPOSITIONS AND METHODS RELATING TO C5L2

#237
20190192627
2019-06-27

Microvascular blood flow decreasing agent and use thereof

#238
20190192482
2019-06-27

Agent for eliminating senescent cells

#239
20190192479
2019-06-27

Immunomodulator

#240
20190191675
2019-06-27

Atopic dermatitis model non-human animal and use thereof

#241
20190183882
2019-06-20

Pulmonary hypertension preventative or therapeutic agent containing component exhibiting selenoprotein P activity-inhibiting effect

#242
20190175684
2019-06-13

Malignant tumor target peptide

#243
20190175590
2019-06-13

Organic compounds

#244
20190175507
2019-06-13

COMPOSITIONS FOR ORAL ADMINISTRATION OF ACTIVE AGENTS

#245
20190169701
2019-06-06

Method of predicting effect of medicinal therapy on cancer

#246
20190169286
2019-06-06

Method for treating IL-8-related diseases

#247
20190169248
2019-06-06

Methods for cardiomyocyte survival, proliferation or differentiation by NRG-2

#248
20190162738
2019-05-30

SALIVARY ABETA42 LEVELS AS PROGNOSTIC INDICATORS FOR ALZHEIMER'S DISEASE

#249
20190161751
2019-05-30

Methods of screening using barcoded libraries

#250
20190160067
2019-05-30

Anti-HTLV-1 drug and therapeutic agent for HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP)

#251
20190151344
2019-05-23

Agent for inducing cell death, agent for suppressing cell proliferation, and pharmaceutical composition used for treatment of disease resulting from abnormal cell proliferation

#252
20190142780
2019-05-16

Use of isothiocyanate compounds

#253
20190134201
2019-05-09

Statin-containing nanoparticle preparation for enhancing function of stem cells for treating inflammatory disease, and functionally enhanced stem cells containing same for treating inflammatory disease

#254
20190134011
2019-05-09

Pharmaceutical composition for the treatment of autism

#255
20190112665
2019-04-18

COMPOSITIONS AND METHODS FOR PROGNOSIS OF OVARIAN CANCER

#256
20190111078
2019-04-18

PRETREATMENT DRUG FOR T CELL INFUSION THERAPY FOR IMMUNE-CHECKPOINT INHIBITOR-RESISTANT TUMOR

#257
20190106505
2019-04-11

Method for treating cancer by administration of antibodies that bind to extracellular region portion of MCEMP1 protein

#258
20190105295
2019-04-11

Method of treatment of obesity

#259
20190099382
2019-04-04

RGD and transferrin nanoparticle composition

#260
20190091330
2019-03-28

Chemoprevention using controlled-release formulations of anti-interleukin 6 agents, synthetic vitamin A analogues or metabolites, and estradiol metabolites

#261
20190091166
2019-03-28

BIOABSORBABLE SHEET OR FILM

#262
20190085041
2019-03-21

Secretory protein

#263
20190083415
2019-03-21

Sustained drug release sheet for treating nerve injury

#264
20190076505
2019-03-14

Immunogenic peptides of SCD1 protein

#265
20190062751
2019-02-28

Tumor cell malignant transformation suppressor and anti-tumor agent

#266
20190062424
2019-02-28

VEGF/DLL4 BINDING AGENTS AND USES THEREOF

#267
20190060255
2019-02-28

ACAT1 inhibitors for treating cancer

#268
20190048077
2019-02-14

Methods and compositions for the prevention and treatment of surgical adhesions

#269
20190046592
2019-02-14

Composition for inducing proliferation or accumulation of regulatory T cells

#270
20190038645
2019-02-07

Agent for overcoming immunosuppression and use thereof

#271
20190030093
2019-01-31

Composition for inducing proliferation or accumulation of regulatory T cells

#272
20190029589
2019-01-31

Therapeutic angiogenesis for treating erectile conditions

#273
20190025300
2019-01-24

Compositions, methods and kits to detect Herpes Simplex virus nucleic acids

#274
20190023657
2019-01-24

Tetrahydronaphthyl urea derivative

#275
20190022325
2019-01-24

Drug container

#276
20190022223
2019-01-24

P2X7 receptor antagonists for restoring T-cell lymphopoiesis in subjects infected with human immunodeficiency virus (HIV)

#277
20190022045
2019-01-24

Marine organism-derived extract, compound, and medical composition having niche formation suppressing activity of leukemic stem cells

#278
20190010225
2019-01-10

Antagonists of IL-6 to raise albumin and/or lower CRP

#279
20190000920
2019-01-03

Methods of treating lung cancer

#280
20180364216
2018-12-20

Choroidal neovascularization suppressor or drusen formation suppressor, and method for assessing or screening for same

#281
20180360819
2018-12-20

ANTI-INFLUENZA VIRUS AGENT AND SCREENING METHOD FOR ANTI-INFLUENZA VIRUS AGENT

#282
20180353535
2018-12-13

GM3-promoted inflammation inhibitor and inflammatory cytokine production inhibitor

#283
20180339022
2018-11-29

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF HEPATOCELLULAR CARCINOMAS

#284
20180334508
2018-11-22

Modulating permeability of the blood cerebrospinal fluid barrier

#285
20180326058
2018-11-15

Combination therapy using T cell redirection antigen binding molecule against cell having immunosuppressing function

#286
20180325940
2018-11-15

Composition for ameliorating loss of hair and graying of hair, and use thereof

#287
20180325937
2018-11-15

Modulation of ciliogenesis

#288
20180325918
2018-11-15

Immunoregulatory agent

#289
20180321246
2018-11-08

Blood biomarker for use in evaluation of effect of drug therapy on kidney cancer

#290
20180319764
2018-11-08

Tricyclic spiro compound

#291
20180311356
2018-11-01

METHOD TO INHIBIT ENDOTHELIAL-TO-MESENCHYMAL TRANSITION

#292
20180311286
2018-11-01

Method of committed differentiation of human induced pluripotent stem cells into Leydig cells and application of Leydig cells

#293
20180311192
2018-11-01

Compositions and methods for the treatment of cancer

#294
20180305449
2018-10-25

VEGF/DLL4 binding agents and uses thereof

#295
20180303938
2018-10-25

Process for treating glaucoma

#296
20180296572
2018-10-18

Replacement of cytotoxic preconditioning before cellular immunotherapy

#297
20180289776
2018-10-11

Methods and compositions related to combined treatment with antiinflammatories and synthetic nanocarriers comprising an immunosuppressant

#298
20180280515
2018-10-04

Stimulus-responsive micellar carrier

#299
20180280315
2018-10-04

Adhesive polymer and medical adhesive patch

#300
20180280304
2018-10-04

Composite granulated product including sugar or sugar alcohol, swelling binder, disintegrating agent and highly absorbent excipient, and method for manufacturing composite granulated product